134 related articles for article (PubMed ID: 19217505)
61. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
[TBL] [Abstract][Full Text] [Related]
62. Gastrointestinal stromal tumors in Saudi Arabia.
Pellicano R; Bokhary R
Saudi Med J; 2010 Sep; 31(9):1076; author reply 1076. PubMed ID: 20844832
[No Abstract] [Full Text] [Related]
63. Neuroendocrine tumors a rare finding: part I.
Jacobs C
Clin J Oncol Nurs; 2009 Feb; 13(1):21-3. PubMed ID: 19193545
[No Abstract] [Full Text] [Related]
64. Appendix Neoplasms in a Rural County: A Review of an Unexpected Number of Cases.
Wood KP; Hoeffner K; Johnson RJ
Am Surg; 2016 Aug; 82(8):e209-11. PubMed ID: 27657571
[No Abstract] [Full Text] [Related]
65. Carcinoid tumors: what should increase our suspicion?
Aggarwal G; Obideen K; Wehbi M
Cleve Clin J Med; 2008 Dec; 75(12):849-55. PubMed ID: 19088003
[TBL] [Abstract][Full Text] [Related]
66. [GIST registry].
Jurecková A; Kocáková I; Vyzula R
Klin Onkol; 2012; 25(2):135-8. PubMed ID: 22577672
[No Abstract] [Full Text] [Related]
67. Comment on Ramage et al.: Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated colon and rectum tumour/carcinoma. Neuroendocrinology 2008;87:31-39.
Scherübl H
Neuroendocrinology; 2008; 88(3):157-8; author reply 158-9. PubMed ID: 18849621
[No Abstract] [Full Text] [Related]
68. Sinonasal malignancies of neuroendocrine origin.
Rischin D; Coleman A
Hematol Oncol Clin North Am; 2008 Dec; 22(6):1297-316, xi. PubMed ID: 19010275
[TBL] [Abstract][Full Text] [Related]
69. [Start of the new German Register for Neuroendocrine Tumors].
Krankenpfl J; 2004; 42(5-6):159. PubMed ID: 15527224
[No Abstract] [Full Text] [Related]
70. Commentary: gastrointestinal stromal tumor.
Froiland K
J Wound Ostomy Continence Nurs; 2010; 37(3):318-9. PubMed ID: 20463548
[No Abstract] [Full Text] [Related]
71. COVID-19 in patients with gastrointestinal stromal tumors: Recommendations for management and vaccination.
Snegarova V; Miteva D; Gulinac M; Peshevska-Sekulovska M; Batselova H; Velikova T
World J Gastrointest Pathophysiol; 2022 Sep; 13(5):170-177. PubMed ID: 36187603
[TBL] [Abstract][Full Text] [Related]
72. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biotherapy.
Oberg K; Ferone D; Kaltsas G; Knigge UP; Taal B; Plöckinger U; ;
Neuroendocrinology; 2009; 90(2):209-13. PubMed ID: 19077379
[No Abstract] [Full Text] [Related]
73. Epidemiology of GIST in the Era of Histology Codes--Letter.
Lin A; Hsing AW; Ravdin PM
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):998. PubMed ID: 26033756
[No Abstract] [Full Text] [Related]
74. Gastrointestinal stromal tumours.
Nat Rev Dis Primers; 2021 Mar; 7(1):21. PubMed ID: 33737509
[No Abstract] [Full Text] [Related]
75. Update on the proposal for creating a guideline for cancer registration of the gastrointestinal tumors (I-2).
Jung ES; Kang YK; Cho MY; Kim JM; Lee WA; Lee HE; Park S; Sohn JH; Jin SY
Korean J Pathol; 2012 Oct; 46(5):443-53. PubMed ID: 23136571
[TBL] [Abstract][Full Text] [Related]
76. Upper gastrointestinal bleeding as the initial manifestation of gastroenteropancreatic neuroendocrine tumors.
Thongtan T; Deb A; Islam S; Nugent K
Proc (Bayl Univ Med Cent); 2021 Sep; 34(5):618-619. PubMed ID: 34456491
[TBL] [Abstract][Full Text] [Related]
77. Clinical Updates for Gastrointestinal Malignancies.
Laface C; Memeo R
J Pers Med; 2023 Sep; 13(9):. PubMed ID: 37763191
[TBL] [Abstract][Full Text] [Related]
78. Introduction: gastrointestinal (GI) malignancies.
Engelking C; Wickham R
Semin Oncol Nurs; 2009 Feb; 25(1):1-2. PubMed ID: 19217501
[No Abstract] [Full Text] [Related]
79. Neuroendocrine Tumors-Less Well Known, Often Misunderstood, and Rapidly Growing in Incidence.
Chauhan A; Kohn E; Del Rivero J
JAMA Oncol; 2020 Jan; 6(1):21-22. PubMed ID: 31697337
[No Abstract] [Full Text] [Related]
80. Proposed Implementation of a Patient-Centered Self-Assessment Tool for Patients with Neuroendocrine Tumors among Academic and Community Practice Sites: The City of Hope Model.
Crook CJ; Yen L; Ta K; Karimi M; Nguyen D; Lee RT; Li D
J Clin Med; 2023 Feb; 12(3):. PubMed ID: 36769875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
